Scholarlink

<p>CRISPR–Cas systems have been explored for targeted genome editing of several organisms. It is rapid, cost-effective, specific, and versatile technology. It requires expression of multidomain single Cas9 protein and single guide RNA (sgRNA) that targets desired nucleic acids in the presence of a&#xa0;protospacer adjacent motif&#xa0;(PAM). This generates a double-stranded break that is repaired by either non-homologous end joining or a homology-directed repair pathway. Currently, several Cas protein variants have been discovered and being used for several biotechnological applications. This review highlights the recent progress of CRISPR–Cas systems for genome editing of mainly human pathogenic microorganisms for their&#xa0;controlling infections.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Advancements in CRISPR–Cas Systems for Genome Editing towards Eradication of Human Microbial Pathogens

  • 期刊论文

  • 发表日期：

    2025年8月20日

查看全文
  • Gargi Bhattacharjee,
  • Nisarg Gohil,
  • Khushal Khambhati,
  • Karan Murjani,
  • Dinh Toi Chu,
  • Nhat Le Bui,
  • Hue Vu Thi,
  • Indra Mani,
  • Abhisheka Bansal,
  • Sasanala Shamili,
  • Lakkakula Satish,
  • Suresh Ramakrishna,
  • Khalid J. Alzahrani,
  • Vijai Singh

摘要

CRISPR–Cas systems have been explored for targeted genome editing of several organisms. It is rapid, cost-effective, specific, and versatile technology. It requires expression of multidomain single Cas9 protein and single guide RNA (sgRNA) that targets desired nucleic acids in the presence of a protospacer adjacent motif (PAM). This generates a double-stranded break that is repaired by either non-homologous end joining or a homology-directed repair pathway. Currently, several Cas protein variants have been discovered and being used for several biotechnological applications. This review highlights the recent progress of CRISPR–Cas systems for genome editing of mainly human pathogenic microorganisms for their controlling infections.

Graphical Abstract